CN Stock MarketDetailed Quotes

603896 Zhejiang Shouxiangu Pharmaceutical

Watchlist
  • 26.44
  • -0.55-2.04%
Market Closed Jun 3 15:00 CST
5.34BMarket Cap19.83P/E (TTM)

Zhejiang Shouxiangu Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
-0.16%1.62B
-1.36%1.5B
45.60%1.42B
112.04%1.7B
130.18%1.62B
124.89%1.52B
70.23%974.62M
14.06%800.04M
3.40%705.67M
1.31%677.98M
Transactional financial assets
----
----
----
----
-73.33%30M
-76.92%30M
-82.35%30M
-45.45%30M
81.45%112.5M
160.00%130M
Notes receivable and accounts receivable
29.50%164.35M
-18.68%111.93M
90.55%119.41M
90.60%109.44M
43.23%126.92M
62.86%137.65M
14.08%62.67M
34.98%57.42M
32.56%88.61M
20.62%84.52M
-Notes receivable
-50.50%18.94M
-13.10%20.84M
--14.28M
--24M
--38.27M
--23.99M
----
----
----
----
-Accounts receivable
64.03%145.41M
-19.86%91.09M
67.76%105.13M
48.81%85.44M
0.04%88.65M
34.48%113.66M
14.08%62.67M
34.98%57.42M
32.56%88.61M
20.62%84.52M
Other receivables (including interest and dividends)
28.83%4.6M
29.63%3.25M
9.87%3.97M
64.30%5.81M
0.97%3.57M
-14.07%2.51M
-1.99%3.61M
5.79%3.54M
24.01%3.54M
15.35%2.92M
-Other receivable
----
----
----
64.30%5.81M
----
-14.07%2.51M
----
5.79%3.54M
----
15.35%2.92M
Advance payment
-20.56%12.07M
47.91%20.66M
-12.45%12.94M
16.91%14.4M
40.25%15.19M
32.11%13.97M
26.09%14.78M
23.19%12.32M
-23.18%10.83M
-24.67%10.57M
Inventories
0.93%166.39M
6.82%157.83M
3.61%179.5M
8.29%185.29M
26.44%164.85M
49.16%147.76M
21.42%173.25M
15.57%171.11M
4.02%130.38M
-0.32%99.06M
Receivable financing
346.51%1.38M
3,396.58%1.13M
-95.13%403.46K
-95.89%364.68K
-99.00%309.08K
-99.90%32.37K
-27.08%8.29M
-35.12%8.88M
40.90%30.99M
179.21%32.73M
Other current assets
220.27%12.04M
49.88%8.08M
-6.34%7.81M
-73.57%2.57M
22.89%3.76M
-28.28%5.39M
203.11%8.33M
399.59%9.72M
61.09%3.06M
91.17%7.51M
Adjustment items of current assets
--0.01
----
----
----
----
----
----
----
----
----
Total current assets
0.69%1.98B
-2.96%1.81B
36.65%1.74B
84.28%2.01B
81.37%1.97B
78.13%1.86B
31.54%1.28B
11.99%1.09B
11.06%1.09B
13.51%1.05B
Non Current assets
Other equity investment
14.98%72.56M
6.39%59.98M
14.67%62.71M
-1.49%62.88M
-0.35%63.11M
-4.26%56.37M
-10.95%54.69M
-1.81%63.83M
-11.63%63.33M
-3.77%58.88M
Other non-current financial assets
----
----
--0
----
-45.65%1.5M
-45.65%1.5M
-90.06%1.5M
-90.06%1.5M
-81.71%2.76M
-81.71%2.76M
Investment real estate
-5.26%220.8M
15.12%223.76M
15.37%227.08M
15.44%230.06M
15.51%233.05M
-4.81%194.38M
-4.76%196.84M
-4.06%199.3M
-4.00%201.75M
-3.95%204.21M
Long-term equity investment
-1.54%5.9M
-3.20%5.74M
-6.93%5.51M
-8.78%5.45M
-4.59%5.99M
23.03%5.93M
12.04%5.92M
11.54%5.97M
12.60%6.28M
-17.57%4.82M
Fixed assets
----
----
----
0.21%347.67M
----
5.45%376.95M
----
-3.73%346.94M
----
79.76%357.45M
Constru in process
----
----
----
-7.40%144.54M
----
47.07%169.63M
----
1,791.18%156.09M
----
-26.00%115.34M
Productive biological assets
-1.98%34.84M
4.01%31.38M
12.20%30.53M
24.27%33.51M
37.86%35.55M
34.64%30.17M
73.70%27.21M
32.01%26.96M
8.98%25.79M
18.28%22.41M
Intangible assets
-8.35%87.76M
297.88%310.98M
296.38%313.77M
17.98%94.81M
17.20%95.76M
-5.81%78.16M
-5.60%79.16M
4.33%80.36M
4.63%81.7M
5.60%82.98M
Long deferred expense
49.85%75.31M
50.15%79.78M
3.14%45.87M
32.72%48.49M
37.27%50.26M
33.07%53.13M
29.29%44.47M
1.36%36.54M
-2.24%36.61M
44.51%39.93M
Deferred tax assets
----
----
----
----
----
----
-0.32%311.98K
-81.06%278.3K
-67.75%366.26K
-64.07%374.33K
Usufruct assets
42.91%34.46M
46.49%35.72M
74.10%35.27M
95.15%37.2M
20.11%24.11M
17.77%24.38M
16.48%20.26M
2.13%19.06M
7.94%20.08M
14.10%20.71M
Other non current assets
804.28%60.65M
38.97%4.95M
-13.90%12.08M
-55.47%7.63M
-67.46%6.71M
-51.18%3.56M
-56.72%14.03M
-2.50%17.13M
43.89%20.61M
598.36%7.3M
Total non current assets
22.34%1.24B
37.55%1.37B
28.71%1.23B
6.11%1.01B
7.21%1.02B
8.40%994.18M
12.25%958.86M
14.52%953.96M
14.12%947.62M
15.39%917.16M
Total assets
8.06%3.23B
11.14%3.17B
33.24%2.98B
47.85%3.03B
46.81%2.98B
45.54%2.86B
22.51%2.23B
13.15%2.05B
12.46%2.03B
14.38%1.96B
Liabilities
Current liabilities
Short term loan
15.18%394.23M
36.34%372.16M
74.74%332M
--367.52M
--342.27M
--272.97M
--190M
----
----
----
Notes payable and accounts payable
-33.47%97.08M
1.29%145.82M
-24.72%116.79M
-16.08%163.3M
-11.61%145.92M
2.24%143.96M
14.55%155.14M
19.81%194.6M
28.77%165.1M
56.13%140.81M
-Accounts payable
-33.47%97.08M
1.29%145.82M
-24.72%116.79M
-16.08%163.3M
-11.61%145.92M
2.24%143.96M
14.55%155.14M
19.81%194.6M
28.77%165.1M
56.13%140.81M
Contract liabilities
20.18%10.55M
8.37%8.98M
26.66%10.06M
-3.39%8.7M
-16.19%8.78M
-2.85%8.28M
-28.42%7.94M
4.09%9.01M
5.52%10.47M
10.50%8.53M
Advance receipts
-17.11%1.35M
50.17%1.13M
-66.79%780.61K
-32.24%1.13M
132.81%1.63M
-30.40%751.68K
--2.35M
--1.67M
--701.27K
--1.08M
Salaries payable
-4.05%18.42M
-9.32%29.09M
3.83%29.81M
5.02%24.56M
7.03%19.2M
13.50%32.08M
21.10%28.71M
23.26%23.38M
16.11%17.94M
21.63%28.26M
Taxs payable
48.05%6.98M
16.01%9.53M
7.50%8.67M
-60.63%3.49M
37.04%4.71M
100.04%8.22M
-25.21%8.06M
155.51%8.86M
-40.21%3.44M
-41.18%4.11M
Other payable (including interest and dividends)
184.51%7.32M
-6.35%5.36M
-56.13%2.76M
231.80%38.1M
-55.30%2.57M
-42.18%5.73M
0.77%6.29M
40.59%11.48M
15.89%5.76M
50.12%9.9M
-Dividend payable
----
----
----
--35.07M
----
----
----
----
----
----
-Other payable
----
----
----
-73.59%3.03M
----
-42.18%5.73M
----
65.35%11.48M
----
73.28%9.9M
Non current liabilities due within one year
44.81%7.92M
147.88%12.08M
66.50%9.81M
91.89%10.09M
7.99%5.47M
-13.48%4.87M
59.52%5.89M
39.32%5.26M
6.56%5.06M
67.16%5.63M
Other current liabilities
16.18%1.15M
9.90%1M
29.13%1.12M
-3.91%974.38K
-14.92%986.58K
-4.96%910K
-19.67%865.64K
-96.35%1.01M
-95.92%1.16M
-96.81%957.48K
Total current liabilities
2.53%545.01M
22.48%585.15M
26.29%511.8M
142.03%617.86M
153.56%531.55M
139.75%477.77M
111.03%405.26M
9.46%255.28M
6.17%209.63M
18.57%199.28M
Current liabilities
Bonds payable
-17.54%346.05M
-17.55%340.19M
269.06%336.33M
269.41%330.64M
372.79%419.67M
371.00%412.59M
0.83%91.13M
-15.06%89.51M
-42.86%88.77M
-53.44%87.6M
Deferred tax liabilities
30.57%5.4M
24.10%3.78M
16.66%4.01M
-13.81%4.13M
2.10%4.14M
-23.50%3.04M
-21.28%3.44M
-2.19%4.8M
-31.18%4.05M
-8.21%3.98M
Long term deferred income
12.77%46.11M
21.03%49.98M
19.51%42.83M
0.51%39.33M
17.61%40.89M
8.04%41.3M
76.73%35.84M
82.50%39.13M
53.79%34.77M
137.12%38.23M
Lease liabilities
62.08%23.81M
50.09%23.97M
104.68%23.6M
122.23%24.96M
27.92%14.69M
19.81%15.97M
-7.53%11.53M
-13.19%11.23M
1.71%11.49M
4.21%13.33M
Total non current liabilities
-12.10%421.38M
-11.63%417.92M
186.58%406.78M
175.85%399.07M
244.71%479.4M
230.39%472.9M
11.33%141.94M
0.01%144.67M
-28.73%139.07M
-35.34%143.13M
Total liabilities
-4.41%966.39M
5.51%1B
67.87%918.58M
154.27%1.02B
189.91%1.01B
177.64%950.67M
71.25%547.2M
5.84%399.95M
-11.18%348.71M
-12.08%342.41M
Shareholders equity
Paid-in capital
2.34%201.83M
2.35%201.83M
2.35%201.83M
2.35%201.83M
29.30%197.21M
29.32%197.2M
29.46%197.2M
30.06%197.2M
2.05%152.52M
3.03%152.5M
Other equity instruments
-21.30%69.77M
-21.30%69.77M
269.98%69.77M
269.99%69.77M
369.69%88.65M
367.54%88.66M
-5.33%18.86M
-20.25%18.86M
-46.51%18.87M
-56.42%18.96M
Capital reserve funds
12.81%966.03M
12.82%966.03M
12.84%966.03M
12.84%966.02M
-4.93%856.3M
-4.89%856.25M
-4.35%856.12M
-2.19%856.12M
10.85%900.71M
17.09%900.22M
Surplus reserve funds
8.90%100.93M
8.90%100.93M
19.92%92.68M
19.92%92.68M
19.92%92.68M
19.92%92.68M
15.18%77.29M
15.18%77.29M
15.18%77.29M
15.18%77.29M
Retained profit
19.76%1.05B
19.49%974.77M
26.98%867.9M
28.86%818.78M
30.58%878.38M
32.93%815.77M
33.99%683.52M
32.91%635.4M
31.84%672.69M
30.87%613.7M
Less:Treasury stock
0.00%165.11M
0.00%165.11M
0.00%165.11M
0.00%165.11M
0.00%165.11M
0.00%165.11M
0.12%165.11M
-13.96%165.11M
-14.14%165.11M
-14.95%165.11M
Other composite income
30.91%33.76M
14.91%23.06M
34.35%25.45M
-4.24%25.6M
-4.39%25.79M
-9.20%20.07M
-21.85%18.94M
-2.09%26.73M
-18.20%26.97M
-8.10%22.1M
Ordinary risk reserve funds
----
----
----
----
----
----
----
----
----
--0
Specific reserves
----
----
----
----
----
----
----
----
----
--0
Attributable parent company shareholders equity adjustment items
----
----
----
----
----
----
----
----
---0.01
----
Shareholders equity without minority interests
14.45%2.26B
13.95%2.17B
22.04%2.06B
22.05%2.01B
17.22%1.97B
17.65%1.91B
12.17%1.69B
15.05%1.65B
18.98%1.68B
22.12%1.62B
Minority interests
----
----
----
----
----
----
-24.53%388.55K
--547.48K
--532.91K
--384.77K
Other items effecting shareholder equity
----
----
----
----
----
----
----
----
--0.01
----
Total shareholder equity
14.45%2.26B
13.95%2.17B
22.01%2.06B
22.01%2.01B
17.18%1.97B
17.62%1.91B
12.15%1.69B
15.08%1.65B
19.02%1.68B
22.15%1.62B
Adjustment items of liabilities and equity
----
----
----
----
----
----
----
----
---0.01
----
Total liabilityies and equity
8.06%3.23B
11.14%3.17B
33.24%2.98B
47.85%3.03B
46.81%2.98B
45.54%2.86B
22.51%2.23B
13.15%2.05B
12.46%2.03B
14.38%1.96B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds -0.16%1.62B-1.36%1.5B45.60%1.42B112.04%1.7B130.18%1.62B124.89%1.52B70.23%974.62M14.06%800.04M3.40%705.67M1.31%677.98M
Transactional financial assets -----------------73.33%30M-76.92%30M-82.35%30M-45.45%30M81.45%112.5M160.00%130M
Notes receivable and accounts receivable 29.50%164.35M-18.68%111.93M90.55%119.41M90.60%109.44M43.23%126.92M62.86%137.65M14.08%62.67M34.98%57.42M32.56%88.61M20.62%84.52M
-Notes receivable -50.50%18.94M-13.10%20.84M--14.28M--24M--38.27M--23.99M----------------
-Accounts receivable 64.03%145.41M-19.86%91.09M67.76%105.13M48.81%85.44M0.04%88.65M34.48%113.66M14.08%62.67M34.98%57.42M32.56%88.61M20.62%84.52M
Other receivables (including interest and dividends) 28.83%4.6M29.63%3.25M9.87%3.97M64.30%5.81M0.97%3.57M-14.07%2.51M-1.99%3.61M5.79%3.54M24.01%3.54M15.35%2.92M
-Other receivable ------------64.30%5.81M-----14.07%2.51M----5.79%3.54M----15.35%2.92M
Advance payment -20.56%12.07M47.91%20.66M-12.45%12.94M16.91%14.4M40.25%15.19M32.11%13.97M26.09%14.78M23.19%12.32M-23.18%10.83M-24.67%10.57M
Inventories 0.93%166.39M6.82%157.83M3.61%179.5M8.29%185.29M26.44%164.85M49.16%147.76M21.42%173.25M15.57%171.11M4.02%130.38M-0.32%99.06M
Receivable financing 346.51%1.38M3,396.58%1.13M-95.13%403.46K-95.89%364.68K-99.00%309.08K-99.90%32.37K-27.08%8.29M-35.12%8.88M40.90%30.99M179.21%32.73M
Other current assets 220.27%12.04M49.88%8.08M-6.34%7.81M-73.57%2.57M22.89%3.76M-28.28%5.39M203.11%8.33M399.59%9.72M61.09%3.06M91.17%7.51M
Adjustment items of current assets --0.01------------------------------------
Total current assets 0.69%1.98B-2.96%1.81B36.65%1.74B84.28%2.01B81.37%1.97B78.13%1.86B31.54%1.28B11.99%1.09B11.06%1.09B13.51%1.05B
Non Current assets
Other equity investment 14.98%72.56M6.39%59.98M14.67%62.71M-1.49%62.88M-0.35%63.11M-4.26%56.37M-10.95%54.69M-1.81%63.83M-11.63%63.33M-3.77%58.88M
Other non-current financial assets ----------0-----45.65%1.5M-45.65%1.5M-90.06%1.5M-90.06%1.5M-81.71%2.76M-81.71%2.76M
Investment real estate -5.26%220.8M15.12%223.76M15.37%227.08M15.44%230.06M15.51%233.05M-4.81%194.38M-4.76%196.84M-4.06%199.3M-4.00%201.75M-3.95%204.21M
Long-term equity investment -1.54%5.9M-3.20%5.74M-6.93%5.51M-8.78%5.45M-4.59%5.99M23.03%5.93M12.04%5.92M11.54%5.97M12.60%6.28M-17.57%4.82M
Fixed assets ------------0.21%347.67M----5.45%376.95M-----3.73%346.94M----79.76%357.45M
Constru in process -------------7.40%144.54M----47.07%169.63M----1,791.18%156.09M-----26.00%115.34M
Productive biological assets -1.98%34.84M4.01%31.38M12.20%30.53M24.27%33.51M37.86%35.55M34.64%30.17M73.70%27.21M32.01%26.96M8.98%25.79M18.28%22.41M
Intangible assets -8.35%87.76M297.88%310.98M296.38%313.77M17.98%94.81M17.20%95.76M-5.81%78.16M-5.60%79.16M4.33%80.36M4.63%81.7M5.60%82.98M
Long deferred expense 49.85%75.31M50.15%79.78M3.14%45.87M32.72%48.49M37.27%50.26M33.07%53.13M29.29%44.47M1.36%36.54M-2.24%36.61M44.51%39.93M
Deferred tax assets -------------------------0.32%311.98K-81.06%278.3K-67.75%366.26K-64.07%374.33K
Usufruct assets 42.91%34.46M46.49%35.72M74.10%35.27M95.15%37.2M20.11%24.11M17.77%24.38M16.48%20.26M2.13%19.06M7.94%20.08M14.10%20.71M
Other non current assets 804.28%60.65M38.97%4.95M-13.90%12.08M-55.47%7.63M-67.46%6.71M-51.18%3.56M-56.72%14.03M-2.50%17.13M43.89%20.61M598.36%7.3M
Total non current assets 22.34%1.24B37.55%1.37B28.71%1.23B6.11%1.01B7.21%1.02B8.40%994.18M12.25%958.86M14.52%953.96M14.12%947.62M15.39%917.16M
Total assets 8.06%3.23B11.14%3.17B33.24%2.98B47.85%3.03B46.81%2.98B45.54%2.86B22.51%2.23B13.15%2.05B12.46%2.03B14.38%1.96B
Liabilities
Current liabilities
Short term loan 15.18%394.23M36.34%372.16M74.74%332M--367.52M--342.27M--272.97M--190M------------
Notes payable and accounts payable -33.47%97.08M1.29%145.82M-24.72%116.79M-16.08%163.3M-11.61%145.92M2.24%143.96M14.55%155.14M19.81%194.6M28.77%165.1M56.13%140.81M
-Accounts payable -33.47%97.08M1.29%145.82M-24.72%116.79M-16.08%163.3M-11.61%145.92M2.24%143.96M14.55%155.14M19.81%194.6M28.77%165.1M56.13%140.81M
Contract liabilities 20.18%10.55M8.37%8.98M26.66%10.06M-3.39%8.7M-16.19%8.78M-2.85%8.28M-28.42%7.94M4.09%9.01M5.52%10.47M10.50%8.53M
Advance receipts -17.11%1.35M50.17%1.13M-66.79%780.61K-32.24%1.13M132.81%1.63M-30.40%751.68K--2.35M--1.67M--701.27K--1.08M
Salaries payable -4.05%18.42M-9.32%29.09M3.83%29.81M5.02%24.56M7.03%19.2M13.50%32.08M21.10%28.71M23.26%23.38M16.11%17.94M21.63%28.26M
Taxs payable 48.05%6.98M16.01%9.53M7.50%8.67M-60.63%3.49M37.04%4.71M100.04%8.22M-25.21%8.06M155.51%8.86M-40.21%3.44M-41.18%4.11M
Other payable (including interest and dividends) 184.51%7.32M-6.35%5.36M-56.13%2.76M231.80%38.1M-55.30%2.57M-42.18%5.73M0.77%6.29M40.59%11.48M15.89%5.76M50.12%9.9M
-Dividend payable --------------35.07M------------------------
-Other payable -------------73.59%3.03M-----42.18%5.73M----65.35%11.48M----73.28%9.9M
Non current liabilities due within one year 44.81%7.92M147.88%12.08M66.50%9.81M91.89%10.09M7.99%5.47M-13.48%4.87M59.52%5.89M39.32%5.26M6.56%5.06M67.16%5.63M
Other current liabilities 16.18%1.15M9.90%1M29.13%1.12M-3.91%974.38K-14.92%986.58K-4.96%910K-19.67%865.64K-96.35%1.01M-95.92%1.16M-96.81%957.48K
Total current liabilities 2.53%545.01M22.48%585.15M26.29%511.8M142.03%617.86M153.56%531.55M139.75%477.77M111.03%405.26M9.46%255.28M6.17%209.63M18.57%199.28M
Current liabilities
Bonds payable -17.54%346.05M-17.55%340.19M269.06%336.33M269.41%330.64M372.79%419.67M371.00%412.59M0.83%91.13M-15.06%89.51M-42.86%88.77M-53.44%87.6M
Deferred tax liabilities 30.57%5.4M24.10%3.78M16.66%4.01M-13.81%4.13M2.10%4.14M-23.50%3.04M-21.28%3.44M-2.19%4.8M-31.18%4.05M-8.21%3.98M
Long term deferred income 12.77%46.11M21.03%49.98M19.51%42.83M0.51%39.33M17.61%40.89M8.04%41.3M76.73%35.84M82.50%39.13M53.79%34.77M137.12%38.23M
Lease liabilities 62.08%23.81M50.09%23.97M104.68%23.6M122.23%24.96M27.92%14.69M19.81%15.97M-7.53%11.53M-13.19%11.23M1.71%11.49M4.21%13.33M
Total non current liabilities -12.10%421.38M-11.63%417.92M186.58%406.78M175.85%399.07M244.71%479.4M230.39%472.9M11.33%141.94M0.01%144.67M-28.73%139.07M-35.34%143.13M
Total liabilities -4.41%966.39M5.51%1B67.87%918.58M154.27%1.02B189.91%1.01B177.64%950.67M71.25%547.2M5.84%399.95M-11.18%348.71M-12.08%342.41M
Shareholders equity
Paid-in capital 2.34%201.83M2.35%201.83M2.35%201.83M2.35%201.83M29.30%197.21M29.32%197.2M29.46%197.2M30.06%197.2M2.05%152.52M3.03%152.5M
Other equity instruments -21.30%69.77M-21.30%69.77M269.98%69.77M269.99%69.77M369.69%88.65M367.54%88.66M-5.33%18.86M-20.25%18.86M-46.51%18.87M-56.42%18.96M
Capital reserve funds 12.81%966.03M12.82%966.03M12.84%966.03M12.84%966.02M-4.93%856.3M-4.89%856.25M-4.35%856.12M-2.19%856.12M10.85%900.71M17.09%900.22M
Surplus reserve funds 8.90%100.93M8.90%100.93M19.92%92.68M19.92%92.68M19.92%92.68M19.92%92.68M15.18%77.29M15.18%77.29M15.18%77.29M15.18%77.29M
Retained profit 19.76%1.05B19.49%974.77M26.98%867.9M28.86%818.78M30.58%878.38M32.93%815.77M33.99%683.52M32.91%635.4M31.84%672.69M30.87%613.7M
Less:Treasury stock 0.00%165.11M0.00%165.11M0.00%165.11M0.00%165.11M0.00%165.11M0.00%165.11M0.12%165.11M-13.96%165.11M-14.14%165.11M-14.95%165.11M
Other composite income 30.91%33.76M14.91%23.06M34.35%25.45M-4.24%25.6M-4.39%25.79M-9.20%20.07M-21.85%18.94M-2.09%26.73M-18.20%26.97M-8.10%22.1M
Ordinary risk reserve funds --------------------------------------0
Specific reserves --------------------------------------0
Attributable parent company shareholders equity adjustment items -----------------------------------0.01----
Shareholders equity without minority interests 14.45%2.26B13.95%2.17B22.04%2.06B22.05%2.01B17.22%1.97B17.65%1.91B12.17%1.69B15.05%1.65B18.98%1.68B22.12%1.62B
Minority interests -------------------------24.53%388.55K--547.48K--532.91K--384.77K
Other items effecting shareholder equity ----------------------------------0.01----
Total shareholder equity 14.45%2.26B13.95%2.17B22.01%2.06B22.01%2.01B17.18%1.97B17.62%1.91B12.15%1.69B15.08%1.65B19.02%1.68B22.15%1.62B
Adjustment items of liabilities and equity -----------------------------------0.01----
Total liabilityies and equity 8.06%3.23B11.14%3.17B33.24%2.98B47.85%3.03B46.81%2.98B45.54%2.86B22.51%2.23B13.15%2.05B12.46%2.03B14.38%1.96B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg